Eli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical History
2 Articles
2 Articles
Eli Lilly's New Weight Loss Drug May Have the Worst Name in Pharmaceutical History
Pharmaceutical company Eli Lilly announced promising clinical trial results this week for a daily pill to treat obesity and diabetes. Besides the good news of minimal side effects and impressive results, though, the pill has an extremely unfortunate quality: its name. The drug, which was first discovered by Chugai Pharmaceutical and licensed to Eli Lilly in 2018, is called "orforglipron," a word so perplexingly unpronounceable — "or fugly pron"?…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage